REGISTER HERE: Webinar Registration - Zoom

The continued presence of medetomidine in the drug supply has necessitated changes to withdrawal management for patients who have opioid use disorder across the healthcare continuum. Patients seeking to start medications for opioid use disorder or who are returning to outpatient settings from inpatient care for opioid and medetomidine withdrawal need continued follow-up to safely taper medications.

This case-based panel discussion will explore the current understanding of treating medetomidine withdrawal in outpatient settings and discuss how to troubleshoot what to do for vital sign abnormalities, medication management if a patient returns to use, and how to decide when patients require hospital admission.

Objectives:

-Describe medication management of patients transitioning from inpatient settings who require tapering of medications used to treat medetomidine withdrawal.

-Describe the clinical factors and considerations in managing medetomidine withdrawal in outpatient settings.

This program will be accredited for CME, Nursing, and Pharmacy credit. FUNDING ACKNOWLEDGMENT: This project was supported by a grant from the Center for Disease Control via the Philadelphia Department of Public Health, No. 1 NH28CE003536-01-0